Cargando…

A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study

Detalles Bibliográficos
Autores principales:	Sönnerborg, A, Mocroft, A, Lundgren, JD, Raben, D, Gatell, J, Vassilenko, A, Hadziosmanovic, V, Bergovac, J, Sørensen, H, Cusini, M, Clumeck, N, Gazzard, B, Rockstroh, J, Zuin, M, D'Arminio Monforte, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112828/ http://dx.doi.org/10.1186/1758-2652-13-S4-O16

Ejemplares similares

Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
por: Sullivan, Ann K., et al.
Publicado: (2013)

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study
por: Raben, D., et al.
Publicado: (2015)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015
por: Raben, Dorthe, et al.
Publicado: (2019)

Clinical management of ageing people living with HIV in Europe: the view of the care providers
por: Boffito, Marta, et al.
Publicado: (2020)

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
por: Kaulich-Bartz, Josee, et al.
Publicado: (2013)

Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers
por: Boffito, Marta, et al.
Publicado: (2020)

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
por: Peters, Lars, et al.
Publicado: (2014)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
por: Viard, JP, et al.
Publicado: (2010)

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
por: Mocroft, Amanda, et al.
Publicado: (2013)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study
por: Reekie, Joanne, et al.
Publicado: (2012)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir-containing regimen with low CD4 counts
por: Merlini, E, et al.
Publicado: (2010)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Caring for women living with HIV: gaps in the evidence
por: Loutfy, Mona R, et al.
Publicado: (2013)

HIV-Infected Late Presenter Patients
por: D'Arminio Monforte, Antonella, et al.
Publicado: (2012)

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
por: Mocroft, A., et al.
Publicado: (2014)

Illness Representations of HIV Positive Patients Are Associated with Virologic Success
por: Leone, Daniela, et al.
Publicado: (2016)

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis
por: Willemse, Sophie, et al.
Publicado: (2019)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
por: Tincati, Camilla, et al.
Publicado: (2012)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016)

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality
por: Efsen, Anne Marie W., et al.
Publicado: (2013)

Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment
por: Tincati, Camilla, et al.
Publicado: (2014)

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
por: Petoumenos, Kathy, et al.
Publicado: (2012)

Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
por: Worm, Signe W., et al.
Publicado: (2009)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Update on HIV in Western Europe
por: Nakagawa, Fumiyo, et al.
Publicado: (2014)

HIV-Indicator Condition Guided Testing in a Hospital Setting
por: Barbanotti, Diletta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u904tmnu0jmivl6e78a183fshh